arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Filana Therapeutics, Inc.

FLNA Health Care Biotechnology: Pharmaceutical Preparations
$0.64
▼ -2.4% Today
as of Oct 23, 12:17 ET
Last 30 days -10.96% Sep 14 → Oct 23
$0.61 $0.72 $0.84 $0.95 $1.06 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$0.66
High
$0.67
Low
$0.64
Volume
$250,084
Avg Vol
$1M
Mkt Cap
$47M
P/E (TTM)
—
Beta
—
52w High
$4.01
52w Low
$0.64
Div Yield
—
Shares Out
$48M

Recent Press Releases & News last 60 days · 3 items

Oct 9 · 12:00 PR GlobeNewswire
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
Oct 1 · 12:01 MT Newswires
Filana Therapeutics Insider Bought Shares Worth $278,132, According to a Recent SEC Filing
Sep 22 · 12:00 PR GlobeNewswire
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

FLNA earnings at a glance

The options market is pricing a move of about ±424.0% after the report, a range of roughly -$2.07 to $3.35 from today's $0.64. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±7.3% on average; after the most recent report on May 7, 2026 it moved -5.6%. That means options currently expect more movement than FLNA has typically delivered. Implied volatility is currently 36%. The share price of $0.64 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.64
$4.01
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+1.7%
50% positive
Latest IV / EM
3590%
EM ±424.0% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.63$-0.44$-0.25$-0.06$0.13 Actual $-0.58Actual $-0.63Actual $-0.61Actual $-0.43Actual $0.13Actual $-0.58Actual $-0.48Actual $-0.18Actual $-0.22Actual $-0.21 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-44M$-32M$-19M$-6M$6M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.21 — — +56.2% -5.6% earnings
Wed Nov 12, 2025Sep/2025 $-0.22 — — — — earnings
Thu Aug 14, 2025Jun/2025 $-0.18 — — — — earnings
Thu May 8, 2025Mar/2025 $-0.48 — — — +9.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.58 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.13 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.43 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.61 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.63 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.58 — — — — financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-11M—$-12M$-45M$-25M—$-31M$-61M
Net income$-10M—$-11M$-44M$-23M—$-28M$6M
EPS (diluted)——$-0.22$-0.92$-0.48—$-0.58$0.13

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$87M$96M$106M$112M$117M$129M$149M$207M
Inventory————————
Total current assets$88M$98M$109M$115M$120M$137M$203M$222M
Total assets$108M$118M$130M$135M$141M$158M$224M$244M
Long-term debt————————
Total liabilities$40M$44M$48M$47M$13M$12M$57M—
Total equity$68M$74M$82M$88M$128M$146M$167M$189M

Implied volatility — last 90 days

82%2902%5721%8540%11359% Jun 07 — IV 2817% · EM ±390.2%Jun 08 — IV 2727% · EM ±360.1%Jun 09 — IV 2895% · EM ±362.7%Jun 10 — IV 3303% · EM ±390.2%Jun 11 — IV 3504% · EM ±387.2%Jun 12 — IV 4027% · EM ±412.0%Jun 15 — IV 5884% · EM ±425.6%Jun 16 — IV 7147% · EM ±422.1%Jun 17 — IV 10191% · EM ±425.6%Jun 22 — IV 997% · EM ±208.2%Jun 23 — IV 1006% · EM ±205.9%Jun 24 — IV 1121% · EM ±224.6%Jun 29 — IV 993% · EM ±176.0%Jun 30 — IV 1196% · EM ±205.9%Jul 01 — IV 1317% · EM ±220.0%Jul 02 — IV 1261% · EM ±204.0%Jul 03 — IV 1327% · EM ±207.3%Jul 06 — IV 1531% · EM ±212.0%Jul 07 — IV 1485% · EM ±196.2%Jul 09 — IV 1956% · EM ±231.1%Jul 10 — IV 2071% · EM ±228.8%Jul 13 — IV 2915% · EM ±243.5%Jul 14 — IV 3488% · EM ±252.3%Jul 15 — IV 2848% · EM ±168.2%Jul 16 — IV 6333% · EM ±264.5%Jul 20 — IV 83% · EM ±19.6%Jul 21 — IV 85% · EM ±19.8%Jul 22 — IV 136% · EM ±31.1%Aug 10 — IV 145% · EM ±20.1%Aug 11 — IV 156% · EM ±20.6%Aug 12 — IV 128% · EM ±16.1%Aug 24 — IV 1539% · EM ±321.3%Aug 25 — IV 1545% · EM ±316.2%Aug 26 — IV 1390% · EM ±278.5%Aug 27 — IV 1632% · EM ±319.6%Aug 28 — IV 1715% · EM ±328.3%Aug 31 — IV 1634% · EM ±289.5%Sep 01 — IV 1897% · EM ±326.6%Sep 02 — IV 1850% · EM ±309.0%Sep 03 — IV 2127% · EM ±344.1%Sep 04 — IV 2224% · EM ±347.5%Sep 07 — IV 2509% · EM ±347.5%Sep 08 — IV 2897% · EM ±382.6%Sep 09 — IV 3453% · EM ±432.7%Sep 10 — IV 3506% · EM ±414.1%Sep 11 — IV 3599% · EM ±397.6%Sep 14 — IV 4935% · EM ±412.2%Sep 15 — IV 5856% · EM ±423.6%Sep 16 — IV 8866% · EM ±523.7%Sep 17 — IV 11360% · EM ±474.4%Sep 21 — IV 2169% · EM ±453.0%Sep 22 — IV 2620% · EM ±536.0%Sep 23 — IV 1635% · EM ±327.5%Sep 24 — IV 2029% · EM ±397.5%Sep 25 — IV 2467% · EM ±472.1%Sep 28 — IV 2060% · EM ±365.0%Sep 29 — IV 2104% · EM ±362.3%Sep 30 — IV 1985% · EM ±331.6%Oct 01 — IV 2017% · EM ±326.3%Oct 02 — IV 2144% · EM ±335.1%Oct 06 — IV 3678% · EM ±485.8%Oct 07 — IV 4892% · EM ±613.0%Oct 08 — IV 3590% · EM ±424.0%

Sector peers

EDSA
Edesa Biotech, Inc.
$46M $2.70-5.3%
CRVO
CervoMed Inc.
$48M $2.27-3.0%
HOWL
Werewolf Therapeutics, Inc.
$45M $1.02-1.0%
VERU
Veru Inc.
$44M $2.300.0%
SER
Serina Therapeutics, Inc.
$50M $1.74-1.9%
GRCE
Grace Therapeutics, Inc.
$43M $1.90-3.8%

FLNA earnings FAQ

What is FLNA's expected move for earnings?

Options currently price a move of about ±424.0%, or $2.71 per share either way from $0.64.

How does FLNA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±7.3%, up 1 times and down 1 times.

What is FLNA's implied volatility?

FLNA's at-the-money implied volatility is about 36% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in